Short communication: Feeding a rumen-degradable amino acid affects plasma thyroxine and triiodothyronine concentrations.

Our previous published work demonstrated that feeding rumen-degradable valine to late-lactation dairy cows increased milk production compared with control-fed cows, with a response that was equivalent to that of recombinant bovine somatotropin. To further elucidate the response mechanism, we hypothesized that thyroxine (T4) and triiodothyronine (T3), which are important regulators of basal metabolism, may be involved. Previous short-term studies have demonstrated increased milk production when feeding iodinated casein. Eight multiparous Holstein dairy cows (255 ± 26.4 d in milk) were blocked by milk yield (34.1 ± 8.25 kg/d) and randomly assigned to 1 of 4 treatments using a replicated 4 × 4 Latin square design with 21-d periods (7 d for dietary adaptation and 14 d for data collection). Treatments were control (CON), a single injection of recombinant bovine somatotropin (rbST), and synthetic valine fed at 40 (V40) or 80 (V80) g/cow per day. Cows were fed a total mixed ration with a distillers dried grains carrier fed at 113.4 g/d containing no valine or added valine. Blood samples were collected twice during wk 2 and 3 of each period for T3 and T4 analysis. Concentrations of T4 (3.28, 3.90, 3.98, and 3.87 µg/dL for CON, rbST, V40, and V80, respectively) were increased for cows receiving rbST, V40, and V80 compared with CON cows. Concentrations of T3 (125.7, 140.7, 148.8, and 139.7 ng/dL) were increased for cows receiving rbST, V40, and V80 compared with CON cows, with cows receiving V40 having the highest T3 concentrations. In conclusion, feeding rumen-degradable valine increases plasma T4 and T3 concentrations, which would explain the mechanism leading to increased milk production.

Effects of treatment of preweaning dairy calves with recombinant bovine somatotropin on immune responses and somatotropic axis.

Weaning may be associated with negative energy balance and body weight loss when calves are still immunologically immature, predisposing them to infectious diseases. The aim of the present experiment was to investigate the effects of treatment of preweaning dairy calves with recombinant bovine somatotropin (rbST) on the somatotropic axis, selected immune parameters, and hematology of calves around weaning. Thirty-six Holstein female calves were randomly assigned to receive 1.5 to 1.8 mg of rbST (Posilac, Elanco Animal Health, Greenfield, IN) per kilogram of body weight or to receive injections of saline (saline solution 0.9%, Valley Vet Supply, Marysville, KS) every 7 d from 21 to 63 d of life. Calves were fed milk replacer ad libitum from birth to 38 d of age (d -11), when progressive weaning started, and calves were weaned at 49 d of age (d 0). Calves were weighed at birth and weekly from 21 to 63 d of age, when wither height also was measured. Calves were vaccinated with 0.5 mg of ovalbumin on study d -28 and -7. Blood samples were collected on d -28, -25, -21, -11, 0, 3, 7, and 14. Polymorphonuclear leukocytes were isolated and challenged ex vivo with Escherichia coli to determine phagocytosis and oxidative burst capacity. Additionally, expression of cluster of differentiation (CD)62L and CD18 by granulocyte, lymphocyte, and CD14+ monocyte were determined. Blood samples were also used to determine hematological parameters and concentrations of growth hormone, insulin-like growth factor-1, insulin, glucose, fatty acids, ß-hydroxybutyrate, haptoglobin, and anti-ovalbumin IgG. Calves treated with rbST had greater concentrations of growth hormone and insulin-like growth factor-1 from d -25 to 14 than control calves, whereas insulin, fatty acid, and ß-hydroxybutyrate concentrations did not differ. On d -11, glucose concentration was greater for rbST-treated calves. Treatment did not affect polymorphonuclear lymphocyte phagocytosis and oxidative burst, but intensity of expression of CD62L and CD18 by granulocytes tended to be increased by rbST treatment. Treatment did not affect the concentration of anti-ovalbumin IgG in serum. Haptoglobin concentration was reduced in rbST treated calves on d 3 and we noted a tendency for hematocrit to be lower in rbST-treated calves. Treatment did not affect body weight, wither height, and average daily gain, despite the fact that rbST-treated calves had lower daily milk replacer intake. The relatively minor improvements in immune responses resulting from rbST treatment of weaning calves may not be sufficient to reduce the incidence of infectious diseases.

Effects of cinnamaldehyde or monensin on performance of weaned Holstein dairy heifers.

The objective of this 70-d study was to determine the effects of the essential oil cinnamaldehyde compared with the ionophore monensin on performance of weaned Holstein dairy heifers. Eighty-four Holstein dairy heifers (91 ± 3.33 d of age; 109 ± 7.55 kg) were housed in a naturally ventilated curtain sidewall, straw-bedded barn in 12 pens with 7 heifers/pen (3.98 m2/head). Heifers were randomly assigned to 1 of 4 treatments in a completely randomized design: (1) control (CON; carrier, 908 g of ground corn), (2) monensin sodium [MON; 1 mg/kg of body weight (BW) + carrier], (3) cinnamaldehyde (CIN1; 1 mg/kg of BW + carrier), or (4) cinnamaldehyde (CIN2; 2 mg/kg of BW + carrier). The treatments were hand-mixed into a 20% crude protein (CP) whole shelled corn and protein pellet mix fed at 2.21 kg/heifer daily. Heifers had access to free-choice hay and water daily. Initial BW and hip heights were taken at the start of the study and every other week thereafter until calves reached 23 wk of age. Blood samples were also taken on each weigh day to determine plasma urea nitrogen, glucose, and insulin-like growth factor-1 concentrations. Fecal samples were taken from the same 3 heifers/pen initially and then at d 28, 56, and 70 of the study for coccidia counts. Cinnamaldehyde had no performance effects on growth, hay intake, hip height, or blood metabolites compared with MON or CON. Average daily gains were 0.98, 0.99, 1.01, and 1.03 kg/d, and average hay intakes per pen were 17.08, 16.34, 18.11, and 17.60 kg/d for CON, MON, CIN1, and CIN2, respectively. Fecal samples by pens indicated the presence of viable coccidia, but the counts were low and not consistent across heifers within each pen. No benefits were associated with supplementing cinnamaldehyde or monensin into grain mixes for weaned heifers.

Growth performance of calves fed microbially enhanced soy protein in pelleted starters.

Our objective was to determine effects of feeding calves pelleted starters with microbially enhanced (fungi-treated) soy protein (MSP) in replacement of soybean meal (SBM) with different milk replacers (MR). Thirty-six Holstein calves (2 d old; 24 females, 12 males) in individual hutches were used in a 12-wk randomized complete block design study. Treatments were (1) MSP pellets with MR formulated for accelerated growth (28% crude protein, 18% fat; MSPA), (2) SBM pellets with MR formulated for accelerated growth (SBMA), and (3) MSP pellets with conventional MR (20% crude protein, 20% fat; MSPC). Pellets were similar except for 23% MSP or 23% SBM (dry matter basis). Pellets and water were fed ad libitum throughout the study. Feeding rates of MR on a dry matter basis were 0.37kg twice daily during wk 1, 0.45kg twice daily during wk 2 to 5, and 0.45kg once daily during wk 6. Intakes were recorded daily. Body weights, frame size measurements, and jugular blood samples were collected 2 d every 2 wk at 3 h after the morning feeding. Fecal grab samples were collected 5 times per d for 3 d during wk 12 and then composited by calf for analysis of apparent total-tract digestibility of nutrients using acid detergent insoluble ash as an internal marker. Total and starter pellet dry matter intake were greatest for calves fed SBMA and least for MSPC. Calves had similar average daily gain among treatments, but there was a treatment by week interaction and during the last few weeks of the study calves on MSPC had less body weight compared with MSPA or SBMA. Gain-to-feed ratio was similar among treatments; however, there was a treatment by week interaction. Serum glucose was similar among treatments. Plasma urea nitrogen was greatest for calves fed MSPA and least for MSPC. Plasma concentrations of IGF-1 were greatest for calves fed SBMA. Plasma concentrations of triglycerides were greatest for calves fed MSPC. Plasma concentrations of ß-hydroxybutyrate had a treatment by time interaction. Treatments had similar total-tract dry matter digestibility, but calves fed MSPC had greater crude protein digestibility than SBMA, with MSPA similar to both. Results demonstrated calves fed pelleted starters with MSP had maintained growth performance with less starter intake compared with SBM.

Effects of treatment of periparturient dairy cows with recombinant bovine somatotropin on health and productive and reproductive parameters.

The objectives of the current experiment were to evaluate the effects of treating periparturient dairy cows with recombinant bovine somatotropin (rbST) on incidence of postpartum diseases and performance. Holstein (HO) and Jersey (JS) cows from 2 herds were enrolled in the experiment at 253 ± 3 d of gestation and assigned to the control (n = 432) and rbST125 (n = 437) treatments. Cows in the rbST125 treatment received 125 mg of rbST, weekly, from -21 to 21 d relative to calving. Blood sampled weekly, from -21 to 21 d relative to calving, from a subsample of cows was used to determine the concentrations of growth hormone (GH, HO = 106) and insulin-like growth factor 1 (IGF-1, HO = 147 and JS = 49). Cows were scored for body condition (BCS) at enrollment and at 1 ± 3, 30 ± 3, and 60 ± 3 d in milk (DIM). Cows were milked thrice daily and energy-corrected milk (ECM) yield was recorded for the first 30 DIM. Treatment of cows with rbST resulted in greater concentrations of GH during the prepartum (log10 back-transformed concentrations of GH: HO-control = 7.83 and HO-rbST125 = 10.36 ng/mL) and postpartum (log10 back-transformed concentrations of GH: HO-control = 10.45 and HO-rbST125 = 18.47 ng/mL) periods. Similarly, IGF-1 concentrations were higher during the prepartum (HO-control = 115.1 ± 4.9, HO-rbST125 = 137.7 ± 4.7, JS-control = 120.2 ± 8.3, JS-rbST125 = 167.1 ± 8.1 ng/mL) and postpartum (HO-control = 61.3 ± 4.0, HO-rbST125 = 75.2 ± 3.8, JS-control = 35.5 ± 6.9, JS-rbST125 = 54.6 ± 6.9 ng/mL) periods for rbST-treated cows. During the prepartum period, BCS was not affected by treatment, but during the postpartum period, BCS was reduced for rbST-treated cows (HO-control = 3.00 ± 0.03, HO-rbST125 = 2.90 ± 0.03, JS-control = 2.64 ± 0.02, JS-rbST125 = 2.61 ± 0.02). Cows from the rbST125 treatment tended to have lower incidence of retained fetal membranes (HO-control = 14.3, HO-rbST125 = 6.1, JS-control = 1.5, JS-rbST125 = 1.2%) and had reduced incidence of metritis (HO-control = 26.2, HO-rbST125 = 16.6, JS-control = 19.9, JS-rbST125 = 13.3%) compared with control cows. Ketosis incidence tended to be higher for rbST125 cows (HO-control = 9.4, HO-rbST125 = 11.3, JS-control = 8.5, JS-rbST125 = 13.4%) compared with control cows. The interaction between treatment and herd tended to affect yield of ECM during the first 30 DIM because HO cows treated with rbST during the periparturient period had greater yield than control HO cows (HO-control = 35.5 ± 1.0 vs. HO-rbST125 = 39.4 ± 1.0 kg/d), but treatment with rbST did not affect yield of ECM of JS cows (JS-control = 26.7 ± 0.6 vs. JS-rbST125 = 27.8 ± 0.6 kg/d). Treatment of periparturient dairy cows with 125 mg of rbST decreased the incidence of uterine disorders in HO and JS cows and increased yield of ECM during the first 30 DIM among HO cows, despite slightly increasing the incidence of ketosis.

Evaluation of camelina meal as a feedstuff for growing dairy heifers.

The objective of this research was to compare the growth performance, metabolic profile, and nutrient utilization of dairy heifers fed camelina meal (CAM), linseed meal (LIN), or distillers dried grains with solubles (DDGS). A 12-wk randomized complete block design study was conducted using 33 Holstein and 9 Brown Swiss heifers (144.8±22d of age) with 3 treatments. Treatments were 10% of the diet as CAM, LIN, or DDGS (dry matter basis). All diets contained 60% grass hay and 40% concentrate mix. Diets were balanced with corn and soybean meal to be isonitrogenous and comparable in energy content. Diets were individually limit-fed to 2.65% of body weight using a Calan gate feeding system. Frame sizes, body weights, and body condition scores were measured on 2 consecutive days during wk 0, 2, 4, 6, 8, 10, and 12. Jugular blood samples were taken at the beginning of the study and then every 4wk throughout at 3.5h postfeeding for analysis of blood metabolites and metabolic hormones. Rumen fluid samples were taken at the same time as blood sampling via an esophageal tube during wk 8 and 12. Over the duration of the study, dry matter intake and average daily gain were similar among treatments. Body weights tended to be less for heifers fed CAM and greatest for LIN. Gain to feed was similar for the CAM and DDGS and greatest for the LIN. Overall, most frame measurements were similar among treatments. Body length had a tendency to be greater for CAM compared with LIN with DDGS similar to both. Body condition scores were greater for CAM and DDGS compared with LIN. Rumen total volatile fatty acids, acetate:propionate, and pH were similar among treatments. Butyrate was less in the CAM treatment, intermediate for LIN, and greatest for DDGS. Rumen ammonia was less in DDGS compared with CAM and LIN, which were similar. Blood concentrations of glucose, triglycerides, plasma urea N, and cholesterol were similar among treatments. Metabolic hormones, including insulin-like growth factor-1 and thyroid hormones triiodothyronine and free thyroxine, were similar among treatments. Heifers fed CAM had lesser insulin concentration than other treatments. Total-tract digestion of nutrients were similar among treatments, but CAM tended to have greater digestion of organic matter compared with LIN, with DDGS similar to both. Feeding CAM maintained growth performance compared with DDGS and LIN. This study demonstrates that CAM can be used as a protein source for growing dairy heifers.

Feeding fat from distillers dried grains with solubles to dairy heifers: II. Effects on metabolic profile.

The objective of this study was to determine if increased dietary fat from dried distillers grains with solubles (DDGS) in diets of growing heifers affected metabolic profile, plasma fatty acid profile, and reproductive maturation. Thirty-three Holstein heifers (133±18 d of age) were used in a 24-wk randomized complete block design with 3 treatment diets. Treatment diets were (1) control (CON) containing ground corn (15.9% of DM) and soybean products (17.9%), (2) low-fat (LFDG) containing low-fat DDGS (21.9%) and ground corn (11.9%), or (3) high-fat (HFDG) with traditional DDGS (33.8%). Diets were isonitrogenous and isocaloric, but the HFDG diet was formulated to contain 4.8% fat compared with 2.8% in the CON and LFDG diets. All 3 diets were limit-fed to 2.45% of body weight on a dry matter basis, and resulted in a mean average daily gain of 0.96kg/d across treatments. Every 4wk, jugular blood was collected for analysis of metabolites and metabolic hormones. During wk20 of the feeding period, blood samples were collected for analysis of plasma fatty acid profiles. When heifers weighed between 200 and 300kg of body weight, coccygeal blood samples were taken twice weekly for analysis of progesterone to determine if puberty had been reached. Plasma concentrations of nonesterified fatty acids were similar among treatments and consistent over the duration of the study. Plasma concentrations of ß-hydroxybutyrate, insulin, insulin-like growth factor-1, and leptin were similar among heifers fed each treatment diet, but increased over the duration of the feeding period. Serum concentrations of glucose tended to be less in heifers fed HFDG compared with heifers fed the CON diet. Glucose concentrations fluctuated throughout the feeding period, but no treatment by time interactions were noted. Plasma urea N concentrations were less in heifers fed LFDG compared with heifers fed HFDG and CON diets. The concentrations of plasma urea N increased over the duration of the feeding period, with no treatment by week interaction. Total plasma cholesterol was greater in heifers fed HFDG compared with the CON and LFDG diets, and a significant week effect and a week by treatment interaction were observed. Fatty acid profiles also differed among treatments based on the supply of fatty acids from the diet. Progesterone analysis indicated that heifers fed HFDG tended to be pubertal at a younger age than heifers on CON. These results demonstrate that dietary fat from DDGS can be used in high-plane of nutrition rations for growing heifers and maintain metabolic energy status compared with starch from corn, but alters the concentrations of different blood lipids.

Effects of decreased estradiol-17beta on the serum and anterior pituitary IGF-I system in pigs.

To further delineate the role of estradiol in the IGF system an experiment was conducted to determine the dosage of the aromatase inhibitor, anastrozole, needed to decreases serum concentrations of estradiol-17beta (E2) in maturing boars. A second experiment was conducted to determine if administration of anastrozole to growing boars decreased serum concentrations of E2 and affected components of the serum and anterior pituitary gland (AP) IGF system vs untreated boars and barrows. In Experiment 1, 12 crossbred boars (292 days, 158 kg) were administered either 0, 1 or 10 mg/day anastrozole (n = 4/group) beginning on day 1. Blood samples were collected every 7-14 days. Mean serum concentrations of E2 were decreased (P < 0.05) in the 10 mg group vs the 0 and 1 mg groups by day 36; however, no difference (P > 0.05) existed between the 0 and 1 mg groups. In Experiment 2, 24 crossbred boars and 12 barrows (101 days, 44 kg) were stratified by litter to one of three treatment groups (n = 12): boars administered 10 mg/day anastrozole, boars administered 0 mg/day, and barrows administered 0 mg/day. Blood samples were collected and pigs were weighed on day 0 and every 14 days thereafter, then killed on day 84 when blood and APs were collected. The 10 mg/day pigs were fed the anastrozole-amended diet beginning on day 1. Mean serum concentrations of E2 did not differ (P > 0.05) between the 10 mg/day pigs and 0 mg/day pigs on day 0; however, on day 15 through to 84 mean serum concentrations of E2 were greater (P < 0.05) in 0 mg/day pigs than in the 10 mg/day pigs. Mean percentage increase in serum concentrations of IGF-I was greater (P < 0.05) in untreated boars than anastrozole-treated boars and barrows from day 58 through to 84. Mean percentage of basal IGF-I increased (P < 0.05) from day 29 through to 84 in untreated boars. Mean relative amounts of AP IGF-binding protein (IGFBP)-2 and -5 were less (P < 0.01) in 10 mg/day pigs than in the 0 mg/day pigs, but each was greater (P < 0.01) than in barrows administered 0 mg/day. These results indicate anastrozole administered at a dosage of 10 mg/day suppresses serum concentrations of E2 in pigs. Administration of anastrozole to boars reduced the percentage increase in serum concentrations of IGF-I and relative amounts of AP IGFBP-2 and -5. These data further support a role for E2 in regulating components of the IGF system in pigs.

Antagonism of central vasopressin receptors blocks hypoglycemic stress induced inhibition of luteinizing hormone release in male rhesus macaques.

The first objective of this study was to investigate whether the inhibitory effect of insulin-induced hypoglycemia (IIH) on luteinizing hormone (LH) secretion was the same in unrestrained adult male rhesus macaques as has been previously reported in restrained female macaques. Since IIH did inhibit pulsatile LH secretion in adult male macaques, and some previous studies have implicated arginine vasopressin (AVP) as a central mediator of this inhibition, the second objective was to investigate whether antagonism of AVP action could reverse the IIH-induced inhibition of LH release in males. Ten adult male rhesus macaques (Macaca mulatta) were studied during 15-h periods (07.00-22.00 h), with blood samples collected every 15-min. There were three experimental groups; controls (n = 5), IIH (n = 6) and IIH plus vasopressin antagonist (AVPa; n = 6). During the hypoglycemia studies, the first 5 h served as a control for that occasion and an insulin bolus of 1 U/kg was administered intravenously at 12.00 h. During the IIH plus AVPa, the vasopressin antagonist was infused intravenously from 12.00 h to 17.00 h. LH and testosterone decreased progressively after the insulin bolus in the IIH group reaching a minimum value at 4 h after the infusion. However, compared to the preinfusion levels, secretion of LH and testosterone was not suppressed by hypoglycemia in the group treated with the AVP antagonist. The present study shows that in male macaques not subjected to the psychological stress of restraint, IIH suppresses LH and testosterone secretion. This inhibition of LH release can be blocked in some animals by antagonism of central vasopressin receptors, suggesting that vasopressin is involved in the suppression of gonadotropin releasing hormone/LH release induced by hypoglycemia.

Cellular cadmium responses in subpopulations T20 and T27 of human lung carcinoma A549 cells.

Subpopulations T20 and T27, cloned from the human lung carcinoma line A549, differ significantly in their Cd2+ cytotoxic response. T27 has an LC50 of 31 microM Cd2+ and a cytotoxic response threshold of 5 microM Cd2+, whereas the T20s LC50 is 15 microM Cd2+ and there is no observed threshold for cytotoxicity. Cadmium-induced metallothionein (MT) synthesis, cadmium accumulation, glutathione (GSH) content, and Cd2(+)-induced changes in GSH content were studied in T20 and T27 in an attempt to determine the mechanism(s) causing differential cytotoxic response. MT synthesis measured by following Cd2(+)-induced [35S] incorporation into MT was found not to differ between T20 and T27. There is, however, a difference in Cd2+ accumulation between the two subclones. T20 and T27 cells were exposed to 5 microM Cd2+ for different times or to different concentrations of Cd2+ for 8 h. The T27 subline, which is the more Cd2+ resistant, was found to accumulate significantly more Cd2(+)-both as a function of time exposed to Cd2+ and as a function of Cd2+ concentration. The two subpopulations were found to have comparable initial GSH contents, but showed different Cd2(+)-induced changes in [GSH] when the cells were exposed to 5 microM Cd2+. T27 cells maintained their GSH content following Cd2+ exposure but T20 cells showed a Cd2(+)-induced decrease in GSH content. The results indicate that the difference in Cd2+ cytotoxic response between A549--T20 and A549--T27 cells is not attributable to alterations in MT synthesis nor to a difference in initial GSH content. Relative Cd2+ cytotoxicity also does not in these cells correlate with relative Cd2+ accumulation. The fact that T27 cells accumulate more Cd2+ and yet are more Cd2+ resistant than T20 cells suggests that T27 cells have a much more effective non-MT mechanism to handle intracellular Cd2+. This may involve different GSH metabolism and/or yet undefined molecular factors.

Lack of a nocturnal rise of serum melatonin in prepubertal gilts.

Experiments were conducted to determine if a nocturnal rise in serum melatonin occurs in prepubertal gilts and whether acute exposure of gilts to light during the dark period abruptly reduces serum concentrations of melatonin. In experiment 1, 12 prepubertal crossbred gilts (Duroc x Hampshire x Chester White x Yorkshire) weighing 96.4 + 1.3 kg at 5.1 + .1 mo of age were housed in an LD cycle of 10:14. Following a 3-wk acclimation period, blood samples were drawn at 1-hr intervals from indwelling jugular catheters. Serum concentrations of melatonin were similar (P greater than .05) among blood samples collected during light and dark periods. In experiment 2, serum concentrations of melatonin did not change (P greater than .05) when gilts were abruptly exposed to light during the normal dark period. In experiment 3, serum concentrations of melatonin were similar (P greater than .05) in blood samples collected at 2-hr intervals under 700 lux of light or in total darkness from gilts maintained in either LD 9:15 or LD 24:0. Data from experiment 4 demonstrated that serum melatonin could be detected in nighttime samples if exogenous melatonin was ingested by gilts at night. Together, these experiments clearly indicate that prepubertal gilts do not exhibit a nocturnal rise in serum melatonin when maintained under short daylengths (10L:14D or 9L:15D), and serum melatonin concentrations are unaffected by abrupt changes in light/dark conditions.

Serum concentrations of melatonin in prepubertal gilts exposed to either constant or stepwise biweekly alteration in scotophase.

Melatonin (MEL), a hormone known to mediate photoperiodic cues, is secreted from the pineal gland in a circadian fashion in numerous species. The transduction of photoperiodic information into the secretion of MEL, however, remains controversial in the pig. To determine whether domestic pigs have a nocturnal increase in serum melatonin when exposed to equatorial photoperiods only, 24 prepubertal gilts (38.7 +/- 0.7 kg; 104.5 +/- 0.8 d) and 12 mature ewes, serving as positive controls, were randomly assigned to one of two environmentally regulated rooms. The light (L):dark (D) schedule in one room remained constant (10 L:14 D), while the other room scotophase (darkness duration) was decreased by 1 hr every 2 wk (Experiment 1). After a 2-wk acclimation to each new schedule, 6 ewes and 6 gilts in each room were bled by venipuncture at 2-hr intervals for 22 hr. Experiment 2 was conducted as described for Experiment 1, except that the LD schedule in one room remained constant (15L:9D) while length of scotophase in the other room was increased by 1 hr every 2 wk. In gilts that were exposed to constant 10L:14D, scotophase MEL in serum averaged 103 +/- 13 pg/ml as compared with 57 +/- 13 pg/ml in the photophase. Using each gilt's initial photophase value as a statistical covariate, scotophase MEL in the constant 10L:14D schedule was higher (P < 0.001) than photophase MEL. A similar analysis of MEL in gilts exposed to stepwise biweekly decreases in scotophase revealed a scotophase elevation (P < 0.05) in only certain LD schedules (i.e., 12L:12D and 13L:11D), but the same trend was present throughout all LD schedules. Subjective examination of individual gilt profiles revealed that 56% of gilts had a nocturnal increase in serum MEL in Experiment 1. However, only 10% of the MEL profiles were closely coupled to the environmental LD periods. Overall, mean serum MEL in gilts was of lesser magnitude and more variable than in ewes. Data from these two experiments suggests that the domestic pig has an inherently weak nocturnal elevation in serum MEL, and the ability to detect these rises is dampened by considerable pig-to-pig variability.

Serum concentrations of melatonin during scotophase and photophase in 3, 4, 5 and 6 months old gilts and barrows.

One-hundred-twenty prepubertal crossbred gilts (Hampshire x Duroc) x (Yorkshire x Landrace) were removed from the nursery at 68.7+/-0.4 days of age and 23.6+/-0.9 kg body weight and relocated to a conventional grower-finisher unit. In addition, 60 barrows of similar genetics were relocated from the nursery at 71.0+/-0.5 days of age and 27.4+/-0.5 kg body weight to the same building. Twelve mature anestrous ewes that weighed 77.0+/-2.4 kg were assigned randomly to one of four pens of equal dimensions among the pens containing pigs. Ewes were included in this study to serve as positive controls since their secretory profiles of melatonin are well characterized. All pigs were bled by jugular venipuncture at approximately 3, 4, 5 and 6 months of age. At each age in the pigs and the mature ewes, a single sample was obtained during photophase and scotophase. Illumination intensity during the period of incandescent lighting averaged 220 1x. Blood collection was initiated approximately 4 h after sunrise and 3.5-4 h after sunset. The proportion of animals that exhibited a nocturnal rise in melatonin (MEL) was similar (P > 0.05) between gilts and barrows, but was higher (P < 0.002) in ewes than in pigs at each age examined. A greater proportion (P = 0.007) of 3 month old barrows had a nocturnal rise of MEL than any other age of barrow. Similarly, there was a tendency (P = 0.06) for more 3 month old gilts to exhibit a nocturnal increase in serum MEL than 4, 5 or 6 month old gilts.

Failure of melatonin implants to alter onset of puberty in gilts.

Forty crossbred gilts (Hampshire x Yorkshire x Landrace x Duroc) weighing 55.4 +/- 0.5 kg at 4.2 +/- 0.1 months of age received either melatonin implants (N = 20) or served as controls (N = 20). Gilts were housed in a temperature controlled room (21 degrees C) with a light (L):dark (D) cycle of 10L:14D. Initially, four implants (12 mg melatonin each, Wildlife Pharmaceuticals, Ft. Collins, CO) were placed in one ear subcutaneously. At 2-week intervals, five, six, seven or eight implants were placed in ears of the gilts (one implant per 11.8 kg body weight). Throughout the trial, blood samples were collected twice weekly by jugular venipuncture. All gilts were exposed to mature boars for 15 min on alternate days. Age of puberty was determined from serum concentrations of progesterone and visual observations of estrus. Serum concentrations of melatonin were elevated (5-10 fold) throughout the trial in those gilts that received melatonin implants. Average daily gain (P = 0.51) and age at puberty (P = 0.57) were similar between gilts that received melatonin implants or no implants. Even though gilts continued to receive melatonin after they attained puberty, elevated serum concentrations of melatonin did not alter the length of subsequent estrous cycles (P = 0.90). These data indicate that elevation of serum concentrations of melatonin via implants did not alter the onset of puberty or length of subsequent estrous cycles.

Administration of estradiol-17beta increases anterior pituitary IGF-I and relative amounts of serum and anterior pituitary IGF-binding proteins in barrows.

Two experiments were conducted to determine whether 1) administration of estradiol-173 (E2) implants to barrows elevates serum concentrations of E2 to levels similar to those of adult boars and subsequently affects the anterior pituitary gland IGF system and 2) administration of E2 to barrows increases serum concentrations of E2, serum and anterior pituitary concentrations of IGF-I, and relative amounts of serum and anterior pituitary IGF-binding proteins (IGFBP), vs boars and unimplanted barrows. In Exp. 1, 20 crossbred barrows (150 +/- 6 d, 103 +/- 8 kg) were administered varying number of E2 implants (0, 2, 3, 4; n = 5/group) on d 1. Blood samples were collected weekly by jugular venipuncture, beginning on d 1. Pigs were killed on d 36 when a blood sample and anterior pituitary were collected. Serum concentrations of E2 were increased (P < 0.05) in pigs with 2,3, and 4 implants vs 0 implants, but no difference (P > 0.05) was detected in serum concentrations of E2 among pigs with 2, 3, and 4 implants. Orthogonal contrasts identified that three or four E2 implants were necessary to increase serum concentrations of E2 to that similar to boars. Serum and anterior pituitary concentrations of IGF-I were increased (P < 0.05) in pigs with 2, 3, and 4 implants vs 0 implants. Relative amounts of anterior pituitary IGFBP-2 and - 5 increased (P < 0.05) in response to administration of E2. In Exp. 2, three treatment groups were randomly allotted by litter; boars (n = 11), E2-implanted barrows (n = 9), and unimplanted barrows (n = 12). A blood sample was taken from all pigs on d 1 and every 14 d thereafter. Implanted pigs received four implants on d 1. Pigs were killed on d 91, when a blood sample and anterior pituitary were collected. Mean serum concentrations of E2 were greater (P < 0.05) in implanted pigs vs boars. Mean serum concentrations of IGF-I (ng/mL) were greater (P < 0.05) in boars (238.7 +/- 6.8) than in implanted barrows (170.2 +/- 8.9) and unimplanted (150.4 +/- 6.7) pigs and tended to be greater (P = 0.08) in implanted vs unimplanted pigs. Mean anterior pituitary concentrations of IGF-I (ng/mg tissue) were greater (P < 0.05) in implanted (773.6 +/- 57.0) pigs than boars (251.9 +/- 51.6) and unimplanted (185.6 +/- 49.4) pigs. Relative amounts of serum IGFBP-2 were greater (P < 0.05) in implanted pigs vs boars. Relative amounts of anterior pituitary IGFBP-2 and -5 were greater (P < 0.05) in boars than in implanted and unimplanted pigs. These data suggest that E2 may influence components of the porcine IGF system in the serum and anterior pituitary. Other gonadal factors present in boars may additionally affect the serum and anterior pituitary IGF system.

Serum concentrations of IGF-I, estradiol-17beta, testosterone, and relative amounts of IGF binding proteins (IGFBP) in growing boars, barrows, and gilts.

The purpose of this research was to determine whether serum concentrations of steroids, IGF-I, and relative amounts of serum IGF-binding proteins (IGFBP) differ in growing boars (n = 11), barrows (n = 11), and gilts (n = 12) from 70 to 140 d of age. Pigs of similar age and weight were housed in pens of three or four and given ad libitum access to a 17% CP corn-soy diet and water. Pigs were weighed and blood samples were collected every 14 d beginning at 70 d of age. Serum concentrations of IGF-I and steroids were determined by RIA and relative amounts of IGFBP were determined by ligand blot analysis. By 84 d of age and continuing through 140 d of age, mean serum concentrations of IGF-I were greater (P < .05) in boars than in barrows or gilts. Relative amounts of 46-kDa IGFBP3 and 28-kDa IGFBP-4 were similar (P > .05) among pigs at 70 d of age; however, boars and barrows had greater (P < .05) relative amounts of 24-kDa IGFBP-4 and 41-kDa IGFBP-3 than gilts. Relative amounts of IGFBP-2 were greater (P < .01) in barrows than in gilts or boars at 70 d of age. From 84 d of age through 140 d of age, relative amounts of both forms of IGFBP-3 and the 28-kDa IGFBP-4 were greater (P < .05) in boars than in gilts or barrows. Relative amounts of IGFBP2 were greater (P < .05) in barrows than in gilts or boars at 98 d of age, but by 140 d of age relative amounts were greater (P < .05) in boars and barrows than in gilts. Mean serum concentrations of estradiol-17beta were similar (P > .05) between gilts and boars at 70 d of age, but by 98 d of age, and continuing through 140 d of age, mean serum concentrations of estradiol-17beta were greater (P < .05) in boars than in gilts. Mean serum concentrations of testosterone in boars increased (P < .05) with increasing age and were greatest at 128 and 140 d of age. Serum concentrations of testosterone were negatively correlated (P < .01) with relative amounts of serum IGFBP-2 but positively correlated (P < .01) with serum concentrations of IGF-I and estradiol-17beta. Serum concentrations of estradiol-17beta were positively correlated (P < .01) with serum concentrations of IGF-I in boars. Changes in serum concentrations of IGF-I and relative amounts of IGFBP resulting from changes in serum concentrations of estradiol-17beta and testosterone may contribute to growth differences observed among sexes.

Influence of daily injections of porcine somatotropin on growth, puberty, and reproduction in gilts.

To determine whether recombinant porcine somatotropin (rpST) alters reproduction, 40 crossbred gilts weighing 59.1 +/- .5 kg at 125 +/- 1 d of age were assigned randomly to an experiment arranged as a 2 x 2 factorial. Eight gilts were given daily injections of diluent until they reached 104 kg BW (DW), and eight received diluent injections until puberty (DP). Twelve gilts were given rpST (4 mg/d) until 104 kg BW (PW) and 12 were given rpST injections until puberty (PP). All gilts were individually fed on an ad libitum basis an 18% CP corn-soybean meal diet (1.2% lysine and 3.1 Mcal/kg of ME). Beginning at 5 mo of age, gilts were exposed 20 min daily to mature boars. Serum concentrations of progesterone were measured weekly from 5 to 8 mo of age to verify age of puberty. Gilts observed in pubertal estrus were mated to two different boars 10 h apart. At 47 +/- 1 d of gestation, gilts were slaughtered to assess fetal development. After 60 d of treatment, serum LH and FSH profiles were determined in blood samples drawn at 20-min intervals for 4 h from eight diluent- and eight rpST-treated gilts fitted with indwelling jugular catheters. By 28 d, feed intake, feed/gain, and blood urea nitrogen were decreased (P less than .005) by rpST. Treatments did not affect (P greater than .05) the proportion of gilts attaining first ovulation (DW = 6/6; DP = 10/10; PW = 7/9; PP = 14/14) or conception rate (DW = 5/6; DP = 7/10; PW = 4/6; PP = 11/12).(ABSTRACT TRUNCATED AT 250 WORDS)

Reduction in age of puberty in gilts consuming melatonin during decreasing or increasing daylength.

Two experiments were conducted to determine whether oral administration of melatonin alters the onset of puberty in gilts during naturally increasing or decreasing daylength. In Exp. 1, 20 crossbred prepubertal gilts weighing 77.5 +/- .5 kg at 171.8 +/- 1.0 d of age were assigned randomly to receive either a daily oral dose of 3 mg of melatonin (MEL) or ethanol vehicle (ETH) at 1530 from August 31 to December 1, 1987 (decreasing daylength). Gilts were exposed to mature boars for 20 min thrice weekly and blood samples were collected twice weekly. Serum concentrations of progesterone were used to establish age at puberty and length of estrous cycle. In Exp. 2, 20 crossbred prepubertal gilts weighing 67.7 +/- .7 kg at 143.8 +/- 1.1 d of age received either MEL or ETH treatment from February 1 to May 15, 1988 (increasing daylength). Age of puberty was less in gilts that received MEL than in gilts that received ETH in both Exp. 1 (198 +/- 3 vs 228 +/- 7 d; P less than .01) and Exp. 2 (183.8 +/- 2.7 d vs 194.3 +/- 3.3 d; P less than .05). Gilts that received MEL reached puberty at a lighter weight than gilts that received ETH in Exp. 1 (95.6 +/- 2.1 vs 112.4 +/- 3.9 kg; P less than .01) and Exp. 2 (88.1 +/- 1.5 vs 96.0 +/- 1.8 kg; P less than .01). Serum concentrations of LH and FSH, length of estrous cycles, and percentage of muscle of carcasses were similar between MEL and ETH gilts.(ABSTRACT TRUNCATED AT 250 WORDS)

Effects of high-protein/low-carbohydrate swine diets during the final finishing phase on pork muscle quality.

The aim of this study was to lower the glycogen stores in pork muscle in order to improve pork muscle quality by feeding an ultra-high-protein/low-carbohydrate (HIPRO) diet. Forty-eight barrows (average live weight = 92 kg) were assigned across five treatments and two replications (four or five pigs per treatment by replication combination). All barrows were fed a control diet (13.1% CP) until their assigned treatment began. A treatment was the number of days the barrows were fed the HIPRO diet prior to slaughter (0, 2, 4, 7, or 14 d). The HIPRO diet (35.9% CP) was 97% extruded soybeans. Daily feed intake and weekly live weights were recorded for all barrows. At-death blood glucose levels were determined. Muscle pH, temperature, and electrical impedance were measured in the longissmus lumborum and semimembranosus muscles at 45 min, 3 h, and 24 h postmortem. Glycolytic potential; Minolta L*a*b* values; visual scores for color, firmness, and marbling; water-holding capacity traits (drip loss, purge loss, and cooking loss); and Warner-Bratzler shear force values were determined in the longissmus thoracis et lumborum. Weight gain per day decreased the longer the pigs were fed the HIPRO diet (P < 0.05). Daily feed intake decreased during the 1st wk on the HIPRO diet but returned to near-control levels during the 2nd wk, which when coupled with the continued decreases in daily gain resulted in substantial decreases in feed efficiency during the 2nd wk on the HIPRO diet (P < 0.05). Blood glucose levels and glycolytic potentials were not lowered by feeding the HIPRO diet (P > 0.05); therefore, no differences in rate of pH decline or ultimate pH among dietary treatments were found (P > 0.05). Likewise, there were no differences among dietary treatments in any of the measured meat quality attributes (P > 0.05). Feeding barrows the HIPRO diet for a time period prior to slaughter decreased feed intake, rate of gain, and feed efficiency and was not effective at lowering glycolytic potential or improving pork muscle quality.

Influence of porcine somatotropin on endocrine and histological variables in gilts.

Thirty-six crossbred gilts (71.7 +/- .9 kg and 140.1 +/- .9 d) were assigned to one of three doses (0, 35, or 70 micrograms.kg BW-1 x d-1) of recombinant porcine somatotropin (rpST). The doses of rpST were adjusted weekly, and i.m. injections continued until d 50. Gilts were pen fed (six gilts/pen) a 17% CP corn-soybean diet (1.2% lysine and 3.2 Mcal of ME/kg). At d 50, feed intake, feed:gain ratios (P = .02), and blood urea nitrogen were decreased (P < .001) by increasing rpST doses, whereas ADG was increased (P = .04) by increasing rpST doses. Injections of rpST did not affect (P > .05) conception rate, age, or weight at puberty. Numbers of blastocysts or corpora lutea observed at d 10.4 +/- 1.5 of gestation (42.2 d after final rpST injection) were unaffected (P > .05) by rpST treatment. Anterior and posterior pituitary weights were increased (P < or = .003) linearly with rpST dose. However, liver, adrenal, and heart weights were unaffected (P > .05) by rpST. After a withdrawal period of 42.2 +/- 2.0 d, rpST increased (P < or = .02) the estimated percentage of lean by 5.8% and longissimus muscle area by 10.4%. Eighteen hours before the initial rpST injection (d 0), 10 gilts per rpST dose were catheterized. Catheterizations were repeated on d 40. The rpST or diluent was given i.m. in the extensor muscle of the neck 1 h after initiation of blood collection. Adrenocorticotropic hormone (1.4 IU/kg BW) was administered through the catheter 3 h after initiation of blood collection.(ABSTRACT TRUNCATED AT 250 WORDS)